Related Experiment Video
Updated: Jun 22, 2026
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Topical thrombins: benefits and risks.
Christopher Lomax1, Oren Traub
1School of Pharmacy, University of Southern California, Los Angeles, California, USA. clomax922@gmail.com
Pharmacotherapy
|June 30, 2009
Summary
Topical thrombins are effective for surgical bleeding control but carry risks. Bovine-derived thrombin has immune risks, while human thrombin has theoretical infection risks.
Area of Science:
- Surgical Hemostasis
- Pharmacology
- Biochemistry
Background:
- Postoperative bleeding is a common surgical complication.
- Various hemostatic agents exist, each with benefits and risks.
- Topical thrombins are widely used in surgery, particularly in cardiovascular and neurosurgical procedures.
Purpose of the Study:
- To review the class of topical thrombins.
- To discuss the safety and efficacy of individual topical thrombin products.
- To contextualize product risks within current literature.
Main Methods:
- Literature review of topical thrombin products.
- Analysis of safety data and FDA warnings.
- Comparison of hemostatic efficacy and risk profiles.
Main Results:
- Topical thrombins are generally safe and effective for intraoperative hemostasis.
- Bovine-derived thrombin carries a risk of immune-mediated coagulopathies (FDA black-box warning).
- Human thrombin carries a theoretical risk of transmitting infections from pooled plasma.
Conclusions:
- Topical thrombins are valuable hemostatic agents.
- Product-specific risks, such as immune reactions or infection transmission, must be considered.
- Informed clinical decision-making requires understanding the literature on topical thrombin safety and efficacy.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...